Circulating tumor cells (CTCs) are shed into the bloodstream from primary tumors, but only
a small subset of these cells generates metastases. We conducted an in vivo genome-wide …

Circulating tumor cells (CTCs) are shed into the bloodstream by invasive cancers, but the
difficulty inherent in identifying these rare cells by microscopy has precluded their routine use …

Blood-based biomarkers are critical in metastatic prostate cancer, where characteristic bone
metastases are not readily sampled, and they may enable risk stratification in localized …

A subset of patients with metastatic melanoma have sustained remissions following treatment
with immune checkpoint inhibitors. However, analyses of pretreatment tumor biopsies for …

Background A variety of dermatoses have been reported in the growing number of patients
treated with immune-checkpoint inhibitors (ICIs), but the current understanding of cutaneous …

Original research: Prediction of severe immune-related adverse events requiring hospital
admission in patients on immune checkpoint inhibitors: study of a population level insurance …

The multiplicity of new therapies for breast cancer presents a challenge for treatment
selection. We describe a 17-gene digital signature of breast circulating tumor cell (CTC)–derived …

Most cancers are detected when they cause symptoms that lead to medical evaluation.
Unfortunately, in too many cases this results in diagnosis of cancers that are locally invasive or …

Objective Catatonia is a neuropsychiatric condition occurring across the age spectrum and
associated with great morbidity and mortality. While prospective cohorts have investigated …

Objective Catatonia is a neuropsychiatric disorder that can occur in the setting of many
illnesses, but the frequency of catatonia diagnosis among hospitalized patients is poorly …